Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sandoz Settlement Sets Date For US Denosumab Entry
Deal With Amgen Ends Litigation, Allowing Prolia/Xgeva Biosimilars To Launch Next Year
Apr 30 2024
•
By
David Wallace
Sandoz will be able to launch in May 2025 • Source: Shutterstock
More from Deals
More from Business